This compound is a deuterium-labeled derivative of a sulfonamide, characterized by a phenyl-substituted oxazole ring and a benzenesulfonamide group. It is primarily used as an active pharmaceutical ingredient in research and pharmaceutical manufacturing.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1219794-90-7
Trimetazidine-d8 Dihydrochloride
active pharmaceutical ingredient
Alpha3-(((1,1-Dimethylethyl)amino)methyl)-6-hydroxy-1,3-benzenedimethan-alpha1,alpha1,alpha3-d3-ol
Deuterated active pharmaceutical ingredient
Metoprolol-D7 Hydrochloride
beta-blocker active pharmaceutical ingredient
(+/-)-Ondansetron-d5 (methylimidazole-d5)
deuterated active pharmaceutical ingredient
Valdecoxib
non-steroidal anti-inflammatory drug
4-(5-Methyl-3-phenyl-1,2-oxazol-4-yl)benzene-1-sulfonyl chloride
Pharmaceutical intermediate for valdecoxib synthesis
5-Methyl-3,4-diphenyl-isoxazole
Pharmaceutical intermediate for parecoxib
Parecoxib
non-steroidal anti-inflammatory drug
4-[3-phenyl-5-(trideuteriomethyl)-1,2-oxazol-4-yl]benzenesulfonamide
LNPDTQAFDNKSHK-FIBGUPNXSA-N
[2H]C([2H])([2H])C1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N